Mei et al. (2007) demonstrated that MSCs engineered to overexpress vasculoprotective factor ANGPT-1 were significantly more effective than MSCs alone in a murine model of acute lung injury (ALI) [13]. The gene discussed is ANGPT1; the disease is acute respiratory distress syndrome.